Fig. 7From: Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progressionExpression of Nostrin transcripts in colon cancer patients at different stages of disease progression. Quantitative real time PCR analysis of Nostrin transcripts with 144 clinical samples stratified based on tumour stage using TissueScan™ qPCR array. β-actin was used as an endogenous control. *p < 0.05, ***p < 0.001Back to article page